A carregar...

Effect of sitagliptin on glucose control in type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery

The present study was a 4-week randomized trial to assess the efficacy and safety of sitagliptin, a dipeptidyl-peptidase-4 inhibitor, in persistent or recurring type 2 diabetes after Roux-en-Y gastric bypass surgery (RYGB). Participants (n = 32) completed a mixed meal test (MMT) and self-monitoring...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Shah, Ankit, Levesque, Kiarra, Pierini, Esmeralda, Rojas, Betsy, Ahlers, Michael, Stano, Sarah, Holter, Marlena, Dutia, Roxanne, Belsley, Scott, McGinty, James, Laferrère, Blandine
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5847464/
https://ncbi.nlm.nih.gov/pubmed/29072800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!